DRAP’s survey on drug price hikes irks pharmaceutical manufacturers
Third-party survey initiated in response to public outcry over rising medicine prices after deregulation of non-essential drugs; PPMA voices concerns over lack of industry stakeholder involvement
Citi Pharma’s veterinary subsidiary begins operations, launching 32 products initially
Citi Veterinary Limited projects a turnover of Rs 1.5 billion for FY 2025-26, with plans to establish Pakistan's first dedicated veterinary Active Pharmaceutical Ingredient (API) plant
Searle secures DRAP’s approval for Denosumab biosimilar injections
Company prepares commercial rollout of 60mg and 120mg doses for osteoporosis and oncology care
Pakistan’s pharma sector eyes US market expansion with new tariff advantage
New tariff policy provides Pakistan a competitive edge over India and China; regulatory approvals from US authorities will be crucial for unlocking this potentialÂ
Government approves exemption for import of unregistered lifesaving drugs for hospitals
Exemption covers anti-cancer, cardiac, and essential lifesaving drugs, allowing hospitals to access therapies not yet registered in Pakistan for another five yearsÂ
Transparency International says some branded medicines in Pakistan cost up to 4,000% more than generics
Transparency International Pakistan urges government to implement generic medicine policy to address significant price disparities between branded and non-branded drugs
Haleon Pakistan targets expansion to 19 countries, aims for 10% export sales share
Haleon plans to boost exports and local manufacturing, with focus on Vietnam, Philippines and local sourcing to reduce import reliance
Pakistan to import insulin from Russia through pharmaceutical joint ventures
Joint ventures to strengthen insulin supply, with focus on local manufacturing and price regulation
Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration
Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas
Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high
Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in salesÂ
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
PSW, DRAP launch digital certificates to boost pharmaceutical exportsÂ
Alongside Digital Certificate of Pharmaceutical Product, DRAP Clearance Gateway now offers Free Sale Certificate, Good Manufacturing Practice Certificate, and No Objection Certificate for exports; initiative to enhance regulatory efficiency
Citi Pharma submits offers for acquisition of leading pharma companyÂ
Non-binding offer is part of Citi’s strategic expansion plans to become largest pharma firmÂ
DRAP orders immediate recall of substandard veterinary injection
Zaktyl-20 batch found substandard; authorities warn of therapy failure and drug resistance risks
Searle is lagging the pharmaceutical sector. Its recovery might be just around the corner
The pharmaceutical company has had lackluster numbers in recent times. All that might be about to change